Body fat and metabolic age as indicators of inflammation and cardiovascular risk

Abstract

Get full access to this article

View all access options for this article.

References

Carbone

Lavie

Arena

. Obesity and heart failure: Focus on the obesity paradox. Mayo Clin Proc 2017; 92: 266–279.

Eckel

Meidtner

Kalle-Uhlmann

et al.

Metabolically healthy obesity and cardiovascular events: A systematic review and meta-analysis. Eur J Prev Cardiol 2016; 23: 956–966.

Hartrumpf M, Kuehnel RU and Albes JM. The obesity paradox is still there: a risk analysis of over 15 000 cardiosurgical patients based on body mass index. Interact Cardiovasc Thorac Surg 2017; 25: 18–24.

Vandanmagsar

Youm

Y-H

Ravussin

et al.

The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 2011; 17: 179–188.

P-L

. Cardiovascular pathobiology of inflammasomes: Inflammatory machinery and beyond. Antioxid Redox Signal 2015; 22: 1079–1083.

Bullón

Cano-García

Alcocer-Gómez

et al.

Could NLRP3-inflammasome be a cardiovascular risk biomarker in acute myocardial infarction patients?

Antioxid Redox Signal 2017; 27: 269–275.

Després

J-P

. Body fat distribution and risk of cardiovascular disease: An update. Circulation 2012; 126: 1301–1313.